Publications by authors named "Edith Langevin"

Claim this Profile
R
Risk assessment and mitigation evaluation of future yellow fever outbreaks under different climate scenarios: Insight from a case study of Brazil.
Tedi Ramaj, Xiaotian Wu, Marco Tosato, Fernando Morelli, Yael Thollot, Edith Langevin

PLoS Negl Trop Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling antibody persistence after MenACYW-TT vaccination and comparative analysis with other quadrivalent meningococcal vaccines.
Laurent Coudeville, Isabelle Bertrand-Gerentes, Céline Zocchetti, Edith Langevin, Siham Bchir

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences of nurses in the United Kingdom for attributes of pediatric hexavalent vaccines: a discrete-choice experiment.
Christine Poulos, Tomas Marcek, Phani Chintakayala, Marco Boeri, Amy Francis, Edith Langevin

Expert Rev Pharmacoecon Outcomes Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Evaluation of Adolescent Vaccination with Serogroup ACWY and C Meningococcal Vaccines in Germany.
Sebastian Gruhn, Manuel Batram, Moritz Wick, Edith Langevin, Stefan Scholz

Infect Dis Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quadrivalent Conjugate Vaccine and Invasive Meningococcal Disease in US Adolescents and Young Adults.
Thomas Shin, Chad R Wells, Affan Shoukat, Lilia Potter-Schwartz, Edith Langevin

JAMA Netw Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences of healthcare providers in Switzerland for attributes of pediatric hexavalent vaccines: a discrete-choice experiment.
Salome Samant, Susanne Oberle, Tomas Marcek, Christine Poulos, Phani Chintakayala, Edith Langevin

Curr Med Res Opin· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in Germany.
Sebastian Gruhn, Manuel Batram, Moritz Wick, Edith Langevin, Stefan Scholz

Infect Dis Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Pneumococcal Vaccine Recommendations and Criteria for Decision Making in 5 Western European Countries and the United States.
Roxane Noharet-Koenig, Katarzyna Lasota, Pascaline Faivre, Edith Langevin

MDM Policy Pract· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 - a secondary database analysis.
Sandra Guedes, Hélène Bricout, Edith Langevin, Sabine Tong, Isabelle Bertrand-Gerentes

BMC Public Health· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYD Tetravalent Dengue Vaccine Performance by Baseline Immune Profile (Monotypic/Multitypic) in Dengue-Seropositive Individuals.
Carlos A DiazGranados, Edith Langevin, Matthew Bonaparte, Saranya Sridhar, Tifany Machabert

Clin Infect Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zika and Dengue Interactions in the Context of a Large Dengue Vaccine Clinical Trial in Latin America.
Betzana Zambrano, Fernando Noriega, Gustavo H Dayan, Doris Maribel Rivera, José Luis Arredondo, Edith Langevin

Am J Trop Med Hyg· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic areas by dengue serostatus.
Gustavo H Dayan, Edith Langevin, Remi Forrat, Betzana Zambrano, Fernando Noriega

Vaccine· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the long-term efficacy of a dengue vaccine against symptomatic, virologically-confirmed dengue disease by baseline dengue serostatus.
Gustavo H Dayan, Edith Langevin, Peter B Gilbert, Yukun Wu, Zoe Moodie

Vaccine· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease.
Chloé Pasin, M Elizabeth Halloran, Peter B Gilbert, Edith Langevin, R Leon Ochiai

PLoS One· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials.
Michal Juraska, Craig A Magaret, Jason Shao, Lindsay N Carpp, Andrew J Fiore-Gartland, Edith Langevin

Proc Natl Acad Sci U S A· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy.
Saranya Sridhar, Alexander Luedtke, Edith Langevin, Ming Zhu, Matthew Bonaparte

N Engl J Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy.
Maia A Rabaa, Yves Girerd-Chambaz, Kien Duong Thi Hue, Trung Vu Tuan, Bridget Wills, Edith Langevin

Elife· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a tetravalent dengue vaccine in children in Latin America.
Luis Villar, Gustavo Horacio Dayan, José Luis Arredondo-García, Doris Maribel Rivera, Rivaldo Cunha, Edith Langevin

N Engl J Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.
Maria Rosario Capeding, Ngoc Huu Tran, Sri Rezeki S Hadinegoro, Hussain Imam H J Muhammad Ismail, Tawee Chotpitayasunondh, Edith Langevin

Lancet· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis